Significance of decoy receptor 3 (Dcr3) and external-signal regulated kinase 1/2 (Erk1/2) in gastric cancer
Open Access
- 6 June 2012
- journal article
- Published by Springer Nature in BMC Immunology
- Vol. 13 (1) , 28
Abstract
Background: Decoy receptor 3 (DcR3), a member of the tumor necrosis factor receptor (TNFR) superfamily, is associated with anti-tumor immunity suppression. It is highly expressed in many tumors, and its expression can be regulated by the MAPK/MEK/ERK signaling pathway. The MAPK/MEK/ERK pathway has been reported to be a regulator in tumor occurrence, development and clonal expansion. External-signal regulated kinase (ERK) is a vital member of this pathway. Results: The expression of DcR3 and ERK1/2 in tumor tissues of gastric cancer patients was significantly higher than the non-cancerous group (P < 0.05). There was no statistical difference among tumor tissues from patients with different ages or gender, and even of different differentiation (P > 0.05). However, in patients with stage I gastric cancer, the DcR3 and ERK1/2 levels were significantly lower than patients with more advanced stages. Conclusions: DcR3 and ERK1/2 play a vital role in the development of gastric cancer, and they may be new markers for indicating the efficiency of gastric cancer treatment in the future.Keywords
This publication has 21 references indexed in Scilit:
- DcR3 induces cell proliferation through MAPK signaling in chondrocytes of osteoarthritisOsteoarthritis and Cartilage, 2011
- Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epitheliaClinical Immunology, 2005
- Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cellsCell Death & Differentiation, 2004
- Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinomaInternational Journal of Cancer, 2003
- Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patientsInternational Journal of Cancer, 2003
- The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomasGastric Cancer, 2002
- TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell CostimulatorImmunity, 2002
- Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene clusterProceedings of the National Academy of Sciences, 2000
- A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated ApoptosisJournal of Biological Chemistry, 1999
- Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancerNature, 1998